0000000001257527

AUTHOR

Salvatore Romeo

showing 17 related works from this author

[S1 Herpes zoster localization: acute urinary retention in woman].

2011

Acute urinary retention in women is rare. The varicella-zoster virus causes inflammatory lesions of the sensory-root ganglions, meninges and, less frequently, spinal cord. Herpes zoster has been reported to affect, although rarely, lower urinary tract innervations, and acute urinary retention can be thought to occur in the presence of sacral dermatome involvement. Usually it is located in S2–4 dermatome and the prognosis for acute urinary retention is benign resolving in about 20 days. We present a case in which the S1 dermatome was interested and acute urinary retention developed. After 10 days of specific therapy and self catheterism the problem resolved.

medicine.medical_specialtySacrumUrinary systemAcyclovirGastroenterologyAntiviral AgentsHerpes ZosterVirusS1 dermatomeInternal medicinemedicineHumansIntermittent Urethral CatheterizationUrinary retentionbusiness.industryMeningesGeneral MedicineMiddle AgedUrinary RetentionSpinal cordSacrumSurgerymedicine.anatomical_structureTreatment OutcomeDermatomeAcute DiseaseFemalemedicine.symptombusinessSpinal Nerve RootsUrologia
researchProduct

Treatment of Severe Post-Prostatectomy Stress Urinary Incontinence Using Advance Sling

2010

Severe stress urinary incontinence (SUI) is usually treated by the implant of artificial sphincter positioned around bulbar urethra. AdVance sling is a functional, non-obstructive, anti-incontinence device that showed good results especially for mild and moderate SUI. We present our experience with AdVance sling in 7 patients with severe SUI unfit for artificial sphincter. Our results, after a follow-up of more than 6 months, showed a continence rate of 28% and an improvement rate of 43%, while 2 patients did not show any benefit. The success of AdVance sling depends on the integrity of urethral sphincter and can be applied also in selected cases for the treatment of severe post-prostatect…

Malemedicine.medical_specialtyUrinary Incontinence Stressmedicine.medical_treatmentUrologyUrinary incontinenceAdenocarcinomaDiabetes ComplicationsProsthesis ImplantationPostoperative ComplicationsHumansMedicinePost prostatectomyAgedRetrospective StudiesProstatectomybusiness.industryProstatectomyUrethral sphincterProstatic NeoplasmsRetrospective cohort studyProstheses and ImplantsGeneral MedicineMiddle AgedAdvance slingCombined Modality TherapyTreatment OutcomeChemotherapy AdjuvantImprovement rateHypertensionRadiotherapy AdjuvantImplantmedicine.symptombusinessUrologia Journal
researchProduct

Does Transfer Capacitive Resistive Energy Has a Therapeutic Effect on Peyronie's Disease? Randomized, Single-Blind, Sham-Controlled Study on 96 Patie…

2017

<b><i>Background/Aims/Objectives:</i></b> We have investigated the clinical and physiological effects of Transfer Capacitive Resistive Energy (TCARE) therapy on men with Peyronie's disease (PD). <b><i>Methods:</i></b> Ninety-six men with PD have been randomized in a 2:1 ratio to receive 3 sessions of TCARE therapy or sham therapy. Pain, penile curvature and erectile function have been assessed before the first treatment and up to 9 months after the end of treatment, using the Visual Analogue Scale for the pain, a goniometer to measure the degree of curvature using at-home photography and an International Index of Erectile Function (IIEF-5) que…

Malemedicine.medical_specialtyTime FactorsVisual analogue scalePeyronie's diseaseUrologyPenile Induration030232 urology & nephrologyPain reliefPainElectric Stimulation TherapyElectric Capacitance03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesElectric ImpedanceMedicineHumansSingle-Blind MethodAdverse effectPenile painAgedPain MeasurementResistive touchscreenErectile failure; Induratio penis plastic; Penile pain; Penis plaque; Peyronie's disease; Transfer capacitive resistive energy; Urology030219 obstetrics & reproductive medicinebusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaPenile ErectionInduratio penis plasticTransfer capacitive resistive energyTherapeutic effectRecovery of FunctionMiddle Agedmedicine.diseaseTreatment OutcomeTolerabilityItalyPhysical therapyPenile painPeyronie's diseasebusinessErectile failurePenis plaquePenisUrologia internationalis
researchProduct

Relationship between PTH and PSA Values in Patients with Pathological Finding of Benign Prostatic Hyperplasia

2012

The functional relationship between parathyroid glands and prostatic gland is commonly very well known. The aim of our study was to investigate the relationship between serum levels of PTH and serum levels of PSA in patients with pathological finding of BPH. According to 261 transrectal ultrasound-guided prostatic biopsies performed from March 2009 to March 2010, 75 patients, responding to our inclusion criteria, were selected. 26 patients (34.6%) ended the study. All patients with high serum levels of PSA (>4 ng/mL), with histological diagnosis of benign prostatic hyperplasia, underwent the assay of serum levels of PTH. We observed high levels of PTH (> 66 pg/mL) in 9 patients (35.2…

MaleProstatic GlandAgingmedicine.medical_specialtyBiopsyProstatic HyperplasiaUrologyProstatic biopsyHistological diagnosisBiopsymedicineHumansIn patientPathologicalAgedCalcifediolAged 80 and overmedicine.diagnostic_testbusiness.industryHigh serumProstateGeneral MedicineMiddle AgedProstate-Specific AntigenHyperplasiamedicine.diseaseParathyroid HormonebusinessUrologia Journal
researchProduct

Genitourinary Symptoms—Patient Help-Seeking and General Practitioner Management: An Outpatient Based Survey at a Tertiary Hospital in Southern Italy

2015

Abstract Introduction General knowledge of most common genitourinary diseases is often lacking. In this survey we evaluated the attention given by patients and general practitioners to genitourinary symptoms, and particularly to hematuria and potential early signs of genitourinary cancer. Methods A structured self-administered questionnaire was administered to outpatients before the urological consultation. The questionnaire consisted of 4 multiple choice questions to record the level of patient awareness of urological symptoms, the importance given to gross hematuria, the interval between the onset and the visit, the regularity of physical examination and the first-level investigations ind…

First episodeGynecologyPediatricsmedicine.medical_specialtyGenitourinary diseasesmedicine.diagnostic_testbusiness.industryUrologyPhysical examinationDelayed diagnosisAsymptomaticHelp-seekingGeneral practitionerSettore MED/24 - UrologiaDelivery of health careMedicineMale Urogenital Diseasesmedicine.symptomFemale urogenital diseasebusinessGenitourinary symptomsHematuriaMale urogenital diseaseUrology Practice
researchProduct

Correlazione tra dosaggio di paratormone ed elevati valori di PSA prebioptici in pazienti con successivo esito istologico di benignità

2012

The functional relationship between parathyroid glands and prostatic gland is commonly very well known. The aim of our study was to investigate the relationship between serum levels of PTH and serum levels of PSA in patients with pathological finding of BPH. According to 261 transrectal ultra- sound-guided prostatic biopsies performed from March 2009 to March 2010, 75 patients, responding to our inclusion criteria, were selected. 26 patients (34.6%) ended the study. All patients with high serum levels of PSA (>4 ng/mL), with histological diagnosis of benign prostatic hyperplasia, underwent the assay of serum levels of PTH. We observed high levels of PTH (> 66 pg/mL) in 9 patients (35.2%)

PSAPTH IPB Biopsia prostaticaSettore MED/24 - Urologia
researchProduct

The genitourinary diseases health-care among patients and general practitioner

2012

Introduction: A general awareness of the most common genitourinary diseases is often lacking.The aim of the present study was to investigate the attention of the general practitioner and of the patient to the genitourinary diseases. An incomplete medical history and/or an inadequate physical examination might be responsible of late diagnosis and improper management. Patients and Methods: A self administered questionnaire was obtained by our outpatients before the urological visit. As a preliminary step we administered a very simple questionnaire consisting of four multiple choice questions: 1) Did your general practitioner examine your external genitalia in the last five years? Did you ask …

GENITOURINARY DISEASES HEALTH-CARE GENERAL PRACTITIONERSettore MED/24 - Urologia
researchProduct

Correlation between BMI and the pathological features of prostate cancer at biopsy

2013

Introduction/Aim: Numerous clinical trials investigated the association between obesity and prostate cancer, but they yielded inconsistent results (1). Obesity has been found to be related to prostatic tumors at more advanced stages and higher Gleason grade when compared with normal population (2). An increased number of biopsy cores has been advocated by some Authors in obese and overweight men due to an increased difficulty and delay in cancer detection (3). The main aim of our research was to correlate Body Mass Index (BMI) with the pathological characteristics of prostate cancer at biopsy. Patients and Methods: Patients with positive prostate biopsy performed for palpable prostate nodul…

BIOPSY OBESITYPROSTATE CANCERSettore MED/24 - Urologia
researchProduct

Può la TECAR (Trattamento Energetico Capacitivo Resistivo) Terapia avere un effetto terapeutico sulla malattia di La Peyronie? Studio di fase 2, rand…

2015

doloreTECAR terapiaDisfunzione erettile (DE)Malattia di La Peyronie (IPP)Settore MED/24 - Urologia
researchProduct

Localizzazione S1 di Herpes Zooster: un raro caso di ritenzione urinaria.

2011

Donna di 46 anni con ritenzione urinaria acuta e stipsi. Presentava piccola vescicola sul dorso del piede sinistro quale unica manifestazione di localizzazione di virus Herpes Zooster a livello sacrale S1. Viene riportato l'esame urodinamico e le risultanze dei test sierologici seriati specifici per l'infezione da virus Varicella Zooster. La paziente è guarita a seguito di terapia specifica con Acyclovir. Il caso riportato dimostra che anche il segmento sacrale S1 contribuisce al controllo della dinamica minzionale

Settore MED/07 - Microbiologia E Microbiologia ClinicaRitenzione d'urina Localizzazione S1 Herpes ZosterSettore MED/26 - NeurologiaSettore MED/24 - Urologia
researchProduct

CHOICE OF ADJUVANT INTRAVESICAL THERAPY IN RECURRING INTERMEDIATE-RISK NMI-BC

2011

Objective: The therapeutic strategy for patients affected by intermediate risk non-muscle invasive bladder cancer (NMIBC) recurring after intravesical therapy is not definitively established. Only few studies have been published on secondline intravesical therapy. BCG is advocated when intravesical chemotherapy fails and is often repeated. On the other hand, some patients that suffer recurrence repeat intravesical chemotherapy. A retrospective analysis of 179 intermediaterisk patients submitted to second-line intravesical therapy is reported. Patients and Methods: The clinical files of patients affected by intermediate risk NMI-BC and submitted to second-line adjuvant intravesical therapy w…

bladder cancer intravesical chemotherapy BCGSettore MED/24 - Urologia
researchProduct

Effetti antalgici della TECAR terapia nel trattamento della patologia di La Peyronie. Studio randomizzato a singolo cieco con gruppo sham su un total…

2014

Scopo del lavoro Abbiamo condotto uno studio randomizzato a singolo cieco con gruppo sham per valutare gli effetti terapeutici della TECAR terapia su 96 pazienti affetti dalla malattia di La Peyronie (IPP) vista l’efficacia di questo trattamento sulle patologie fibrose. Materiali e metodi Novantasei pazienti affetti da IPP randomizzati con rapporto 2:1 sono stati suddivisi in 2 gruppi: gruppo trattato e gruppo sham. Abbiamo valutato l’efficacia TECAR sul dolore, sul grado di incurvamento penieno e sul deficit erettile (DE) al termine del trattamento ed a 1 (FU1) e 3 (FU3) mesi dal termine del trattamento mediante l’utilizzo della scala VAS per il dolore e di questionari specifici per l’IPP …

TECAR Malattia di La PeyronieSettore MED/24 - Urologia
researchProduct

IS VISCERAL ADIPOSITY INDEX (VAI)RELATED TO PROSTATE CANCER DETECTED BY BIOPSY?

2014

association between obesity and prostate cancer, yielding inconsistent results. Metabolic syndrome has been suggested to promote aggressive prostate tumors. In a previous study we failed to detect a relation between Body Mass Index (BMI) and prostate cancer Gleason score (1). BMI, although routinely adopted to measure obesity, has low sensitivity and specificity. A novel sex-specific obesity index, based on waist circumference (WC), BMI, triglycerides (TGs) and high density lipoproteins (HDL), the Visceral Adiposity Index (VAI), has been proposed to estimate the visceral adiposity dysfunction (2). The aim of our preliminary research was to correlate VAI and BMI with the presence of prostate…

obesity prostate cancer gleason scoreSettore MED/24 - Urologia
researchProduct

Urodynamics and Overactive Bladder (OAB). What's the incidence of detrusorial overactivity (DO) and What's the role of isometric detrusorial pressure…

2014

Overactive bladderDetrusorial Overactivity UrodynamicsSettore MED/24 - Urologia
researchProduct

Effetto antalgico “immediato” nella malattia di La Peyronie: TECAR Terapia. Studio di fase uno

2013

Introduzione. Con lo scopo di valutare la TECAR terapia quale nuovo possibile trattamento medico della malattia di La Peyronie (PD), abbiamo condotto uno studio di fase uno senza placebo né gruppo di controllo. La TECAR terapia si basa sull’utilizzo di radiofrequenze in grado di trasferire energia ai tessuti trattati causando movimenti ionici. Ciò provoca una stimolazione cellulare in senso replicativo e riparativo. La TECAR terapia ha ottenuto risultati eccellenti nel trattamento di alcune patologie del tesuto connettivo, così abbiamo deciso di condurre uno studio circa l’applicabilità e la sicurezza della TECAR nel trattamento della PD. MATERIALI E METODI. Da giugno a settembre 2012 sono …

TECAR terapia Malattia di La Peyronie Disfunzione ErettileSettore MED/24 - Urologia
researchProduct

Sospensione del fumo alla prima diagnosi di carcinoma non muscolo invasivo della vescica (NMIBC) e rischio di recidiva

2013

Fumo carcinoma vescicale recidivaSettore MED/24 - Urologia
researchProduct

Urodinamica

2012

Urodinamica
researchProduct